Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “chimeric”

309 pharma patents match "chimeric" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 309
Index total 30,257
Page 7 / 13

Quick answer

This filtered view shows 309 pharmaceutical patents matching "chimeric" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

309 results for “chimeric” · 30,257 patents in full index Clear search

  1. US 11034750

    Chimeric antigen receptor (CAR) comprising a CD19-binding domain

    AUTOLUS LIMITED · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  2. US 11021545

    Multimodal cancer therapy comprising chimeric viral/nonviral nanoparticles and anticancer agents

    The Regents of the University of California · Granted Jun 1, 2021 · Expires May 27, 2041

    granted

  3. US 10988537

    Antibodies comprising chimeric constant domains

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted

  4. US 10981970

    Chimeric antigen receptor (CAR) comprising a CD22-binding domain

    AUTOLUS LIMITED · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  5. US 10975162

    Chimeric antigen receptor

    AUTOLUS LIMITED · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  6. US 10975365

    Di-enzymatic chimeric endolysin

    Government of the United States of America, as represented by the Secretary of Commerce · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  7. US 10968442

    Chimeric clotting factors

    BIOVERATIV THERAPEUTICS INC. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted

  8. US 10934337

    Anti-BCMA chimeric antigen receptors

    Cartesian Therapeutics, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

  9. US 10934363

    Chimeric antigen receptors based on single domain antibodies and methods of use thereof

    LEGEND BIOTECH USA INC. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

  10. US 10919951

    Chimeric antigen receptor

    AUTOLUS LIMITED · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted

  11. US 10900042

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  12. US 10888581

    Chimeric antigen receptor and methods of use thereof

    The Regents of the University of California · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted

  13. US 10881742

    Factor VIII chimeric and hybrid polypeptides, and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted

  14. US 10876123

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  15. US 10869911

    Chimeric protein

    AUTOLUS LIMITED · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  16. US 10844387

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted

  17. US 10837003

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  18. US 10837019

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  19. US 10829769

    Chimeric antigen receptors targeting b-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  20. US 10829767

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  21. US 10829768

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  22. US 10815487

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  23. US 10815488

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  24. US 10815301

    Anti-CD30 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.